Publications by authors named "John Jereb"

Claim this Profile
D
Delayed Tuberculosis Diagnoses During the Coronavirus Disease 2019 (COVID-19) Pandemic in 2020-King County, Washington.
Masahiro Narita, Grace Hatt, Katelynne Gardner Toren, Kim Vuong, Monica Pecha, John A Jereb

Clin Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection.
Amy L Sandul, Nwabunie Nwana, J Mike Holcombe, Mark N Lobato, Suzanne Marks, John Jereb

Clin Infect Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpreting False Positive Tuberculosis Tests in Occupational Screening: The Fault of the Test, the Testing Schedule, or Both?
John A Jereb

Ann Am Thorac Soc· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands.
Sundari R Mase, John A Jereb, Daniel Gonzalez, Fatma Martin, Charles L Daley

Pediatr Infect Dis J· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible Airborne Person-to-Person Transmission of Mycobacterium bovis - Nebraska 2014-2015.
Bryan F Buss, Alison Keyser-Metobo, Julie Rother, Laura Holtz, Kristin Gall, John Jereb

MMWR Morb Mortal Wkly Rep· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis Contact Investigations--United States, 2003-2012.
Kai H Young, Melissa Ehman, Randall Reves, Brandy L Peterson Maddox, Awal Khan, John Jereb

MMWR Morb Mortal Wkly Rep· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-γ release assays for prediction of tuberculosis.
L Masae Kawamura, Jennifer A Grinsdale, Christine S Ho, John A Jereb

Lancet Infect Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring for tuberculosis drug hepatotoxicity: moving from opinion to evidence.
Jussi J Saukkonen, Krista Powell, John A Jereb

Am J Respir Crit Care Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculin skin test conversions in hospital housekeepers.
John A Jereb, Thomas D Privett, Michele L Pearson

Int J Tuberc Lung Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis in indigenous peoples in the U.S., 2003-2008.
Emily Bloss, Timothy H Holtz, John Jereb, John T Redd, Laura Jean Podewils

Public Health Rep· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated preparedness for continuity of tuberculosis care after Hurricanes Gustav and Ike: Louisiana and Texas, 2008.
Mark C Miner, Gail Burns-Grant, Charles DeGraw, Charles Wallace, Carol Pozsik, John Jereb

Public Health Rep· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
Gerald H Mazurek, John Jereb, Andrew Vernon, Phillip LoBue, Stefan Goldberg

MMWR Recomm Rep· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children.
Deborah A Lewinsohn, Mark N Lobato, John A Jereb

Curr Opin Pediatr· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis.
James D Heffelfinger, Pragna Patel, John T Brooks, Helene Calvet, Charles L Daley, John Jereb

Am J Public Health· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
Mark N Lobato, John A Jereb, Kenneth G Castro

Pediatrics· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity.
Mark N Lobato, John A Jereb, Jeffrey R Starke

Pediatrics· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection.
Kashef Ijaz, Peter D McElroy, John Jereb, Thomas R Navin, Kenneth G Castro

Clin Infect Dis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An official ATS statement: hepatotoxicity of antituberculosis therapy.
Jussi J Saukkonen, David L Cohn, Robert M Jasmer, Steven Schenker, John A Jereb

Am J Respir Crit Care Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on the risk of active tuberculosis.
John A Jereb, Lisa J Nelson, Kenneth G Castro

Arch Pediatr Adolesc Med· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection.
Kashef Ijaz, John A Jereb, Lauren A Lambert, William A Bower, Philip R Spradling

Clin Infect Dis· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.
Gerald H Mazurek, John Jereb, Phillip Lobue, Michael F Iademarco, Beverly Metchock

MMWR Recomm Rep· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection.
Peter D McElroy, Kashef Ijaz, Lauren A Lambert, John A Jereb, Michael F Iademarco

Clin Infect Dis· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis associated with therapy against tumor necrosis factor alpha.
Kevin L Winthrop, Jeffrey N Siegel, John Jereb, Zachary Taylor, Michael F Iademarco

Arthritis Rheum· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Arden House Conference on Tuberculosis, revisited: perspectives for tuberculosis elimination in the United States.
John Jereb, Rachel Albalak, Kenneth G Castro

Semin Respir Crit Care Med· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressing toward tuberculosis elimination in low-incidence areas of the United States. Recommendations of the Advisory Council for the Elimination of Tuberculosis.
John A Jereb

MMWR Recomm Rep· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis